Related Experiment Video
Updated: Nov 12, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Consequences of recurrent hypoglycaemia on brain function in diabetes
1Systems Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK. r.mccrimmon@dundee.ac.uk.
Recurrent hypoglycemia, a side effect of insulin therapy, impairs brain glucose regulation and awareness, increasing severe hypoglycemia risk. It also exacerbates oxidative stress, potentially accelerating cognitive decline in diabetes patients.
Area of Science:
- Neuroendocrinology
- Metabolic Disorders
- Cellular Biology
Background:
- Insulin therapy revolutionized diabetes care but carries the risk of iatrogenic hypoglycemia.
- Recurrent hypoglycemia poses significant cellular challenges, particularly within the brain.
Purpose of the Study:
- To review the cellular consequences of recurrent hypoglycemia in the brain.
- To examine the impact on glucose homeostasis and counterregulatory responses.
Main Methods:
- Review of pre-clinical research on cellular adaptations to recurrent hypoglycemia.
- Focus on the ventromedial hypothalamus as a model system.
Main Results:
- Recurrent hypoglycemia induces brain cell adaptations, increasing resilience but impairing hypoglycemia awareness and raising severe hypoglycemia risk.
- Hypoglycemia acts as an oxidative stressor, potentially worsening hyperglycemia-induced stress and inflammation.
- Rebound hyperglycemia post-hypoglycemia exacerbates oxidative stress and inflammation, linked to cognitive decline.
Conclusions:
- Cellular adaptations to recurrent hypoglycemia paradoxically increase severe hypoglycemia risk.
- Hypoglycemia and rebound hyperglycemia contribute to oxidative stress, inflammation, and cognitive decline in diabetes.
- Glycemic variability is a key risk factor for diabetes complications.
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

